| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.5 |